The Lupus Research Institute joined prominent lupus clinicians, researchers and advocates from around the world at the 8th International Congress on SLE in Shanghai this May. The Congress, held every three years, was a global summit for leading specialists in the field of systemic lupus erythematosus, as well as basic researchers and clinical experts of different specialties. The scientific program of the Congress covered cutting-edge development in basic research, the latest advance of clinical management and rapid progress in translational medicine.
The Lupus Research Institute sponsored a key session on biomarkers that covered such topics as:
- pro-inflammatory HDL as a novel biomarker for carotid artery plaque in women with lupus
- the clinical significance and prevalence of antibodies against coagulation factors in people with antiphospholipid antibody syndrome
- the use of certain red blood cell (erythrocyte) levels for monitoring disease activity
- insights into lupus via autoantibody profiles
- biomarkers for differentiating between disease flare and infection in people with lupus
Co-Chair: Bevra Hahn, MD, chief of rheumatology and arthritis at UCLA Medical Center in Los Angeles
Co-Chair: Michael Weisman, MD, director of the division of rheumatology at Cedars-Sinai in Los Angeles
|Maureen McMahon, MD, from UCLA||Nan Shen, MD, from the Shanghai Renji Hospital|
|Shuang Ye, MD, from the Shanghai Renji Hospital||Quan-Zhen Li, MD, from the University of Texas|
“While we are exposed to lupus research done in the US and European countries, meetings like these spotlight lupus research in China and other Asian countries. A sobering fact was the estimated number of lupus patients in these countries. However, it is good to know and keep the hope that the work the Lupus Research Institute is funding here will eventually benefit all lupus patients, whether they come from the US or China or India.” – Umesh S. Deshmukh, PhD, a 2003/2004 LRI grant recipient at the University of Virginia in Charlottesville who is now doing NIH-funded work based on the original LRI research. Dr. Deshmukh won a Young Investigator grant from the S.L.E. Lupus Foundation to attend the International Congress in Shanghai.